
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
ALS results in muscles that are reduced in size (atrophic), weak, and soft, or muscles that are stiff, tight, and spastic.
Clinical Pearl of the Day: Amyotrophic lateral sclerosis (ALS) disease
ALS is a disease that impacts the parts of the nervous system that control voluntary muscle movement.
Explanation:
Sources:






